Literature DB >> 20670034

Characterization of the 4-(benzothiazol-2-yl)phenylnitrenium ion from a putative metabolite of a model antitumor drug.

Mrinal Chakraborty1, Kyoung Joo Jin, Stephen A Glover, Michael Novak.   

Abstract

The 4-(benzothiazol-2-yl)phenylnitrenium ion 11 is generated from hydrolysis or photolysis of O-acetoxy-N-(4-(benzothiazol-2-yl)phenyl)hydroxylamine 8, a model metabolite of 2-(4-aminophenyl)benzothiazole 1 and its ring-substituted derivatives that are being developed for a variety of medicinal applications, including antitumor, antibacterial, antifungal, and imaging agents. Previously, we showed that 11 had an aqueous solution lifetime of 530 ns, similar to the 560 ns lifetime of the 4-biphenylylnitrenium ion 12 derived from the well-known chemical carcinogen 4-aminobiphenyl. We now show that the analogy between these two cations extends well beyond their lifetimes. The initial product of hydration of 11 is the quinolimine 16, which can be detected as a long-lived reactive intermediate that hydrolyzes in a pH-dependent manner into the final hydrolysis product, the quinol 15. This hydrolysis behavior is equivalent to that previously described for a large number of ester metabolites of carcinogenic arylamines, including 4-aminobiphenyl. The major azide trapping product (90% of azide products) of 11, 20, is generated by substitution on the carbons ortho to the nitrenium ion center of 11. This product is a direct analogue of the major azide adducts, such as 22, generated from trapping of the nitrenium ions of carcinogenic arylamines. The azide/solvent selectivity for 11, k(az)/k(s), is also nearly equivalent to that of 12. A minor product of the reaction of 11 with N(3)(-), 21, contains no azide functionality but may be generated by a process in which N(3)(-) attacks 11 at the nitrenium ion center with loss of N(2) to generate a diazene 25 that subsequently decomposes into 21 with loss of another N(2). The adduct derived from attack of 2'-deoxyguanosine (d-G) on 11, 28, is a familiar C-8 adduct of the type generated from the reaction of d-G with a wide variety of arylnitrenium ions derived from carcinogenic arylamines. The rate constant for reaction of d-G with 11, k(d-G), is very similar to that observed for the reaction of d-G with 12. The similar lifetimes and chemical reactivities of 11 and 12 can be rationalized by B3LYP/6-31G(d) calculations on the two ions that show that they are of nearly equivalent stability relative to their respective hydration products. The calculations also help to rationalize the different regiochemistry observed for the reaction of N(3)(-) with 11 and its oxenium ion analogue, 13. Since 8 is the likely active metabolite of 1 and a significant number of derivatives of 1 are being developed as pharmaceutical agents, the similarity of the chemistry of 11 to that of carcinogenic arylnitrenium ions is of considerable importance. Consideration should be given to this chemistry in continued development of pharmaceuticals containing the 2-(4-aminophenyl)benzothiazole moiety.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20670034      PMCID: PMC2921917          DOI: 10.1021/jo101275y

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  40 in total

Review 1.  The development of the antitumour benzothiazole prodrug, Phortress, as a clinical candidate.

Authors:  T D Bradshaw; A D Westwell
Journal:  Curr Med Chem       Date:  2004-04       Impact factor: 4.530

Review 2.  Cytochrome P450 activation of arylamines and heterocyclic amines.

Authors:  Donghak Kim; F Peter Guengerich
Journal:  Annu Rev Pharmacol Toxicol       Date:  2005       Impact factor: 13.820

3.  In vitro, in vivo, and in silico analyses of the antitumor activity of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazoles.

Authors:  Chee Onn Leong; Marie Suggitt; David J Swaine; Michael C Bibby; Malcolm F G Stevens; Tracey D Bradshaw
Journal:  Mol Cancer Ther       Date:  2004-12       Impact factor: 6.261

4.  Dibenzothiazoles as novel amyloid-imaging agents.

Authors:  Chunying Wu; Jingjun Wei; Kuanqiang Gao; Yanming Wang
Journal:  Bioorg Med Chem       Date:  2006-11-16       Impact factor: 3.641

5.  Antitumor benzothiazoles. 8. Synthesis, metabolic formation, and biological properties of the C- and N-oxidation products of antitumor 2-(4-aminophenyl)benzothiazoles.

Authors:  E Kashiyama; I Hutchinson; M S Chua; S F Stinson; L R Phillips; G Kaur; E A Sausville; T D Bradshaw; A D Westwell; M F Stevens
Journal:  J Med Chem       Date:  1999-10-07       Impact factor: 7.446

6.  Reaction of the 4-biphenylnitrenium ion with 4-biphenyl azide to produce a 4,4'-azobisbiphenyl stable product: a time-resolved resonance Raman and density functional theory study.

Authors:  Jiadan Xue; Yong Du; Xiangguo Guan; Zhen Guo; David Lee Phillips
Journal:  J Phys Chem A       Date:  2008-10-29       Impact factor: 2.781

Review 7.  The aryl hydrocarbon receptor in anticancer drug discovery: friend or foe?

Authors:  T D Bradshaw; V Trapani; D A Vasselin; A D Westwell
Journal:  Curr Pharm Des       Date:  2002       Impact factor: 3.116

8.  Hydrolysis and photolysis of 4-Acetoxy-4-(benzothiazol-2-yl)-2,5-cyclohexadien-1-one, a model anti-tumor quinol ester.

Authors:  Yue-Ting Wang; Kyoung Joo Jin; Lauren R Myers; Stephen A Glover; Michael Novak
Journal:  J Org Chem       Date:  2009-06-19       Impact factor: 4.354

9.  Influence of 2-(4-aminophenyl)benzothiazoles on growth of human ovarian carcinoma cells in vitro and in vivo.

Authors:  T D Bradshaw; D F Shi; R J Schultz; K D Paull; L Kelland; A Wilson; C Garner; H H Fiebig; S Wrigley; M F Stevens
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640

10.  DNA damage and cell cycle arrest induced by 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (5F 203, NSC 703786) is attenuated in aryl hydrocarbon receptor deficient MCF-7 cells.

Authors:  V Trapani; V Patel; C-O Leong; H P Ciolino; G C Yeh; C Hose; J B Trepel; M F G Stevens; E A Sausville; A I Loaiza-Pérez
Journal:  Br J Cancer       Date:  2003-02-24       Impact factor: 7.640

View more
  6 in total

1.  Bioactivation of fluorinated 2-aryl-benzothiazole antitumor molecules by human cytochrome P450s 1A1 and 2W1 and deactivation by cytochrome P450 2S1.

Authors:  Kai Wang; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2012-07-10       Impact factor: 3.739

2.  BD750, a benzothiazole derivative, inhibits T cell proliferation by affecting the JAK3/STAT5 signalling pathway.

Authors:  Y Liu; T Yang; H Li; M-H Li; J Liu; Y-T Wang; S-X Yang; J Zheng; X-Y Luo; Y Lai; P Yang; L-M Li; Q Zou
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

3.  Chemistry of ring-substituted 4-(benzothiazol-2-yl)phenylnitrenium ions from antitumor 2-(4-aminophenyl)benzothiazoles.

Authors:  Yang Zhang; Mrinal Chakraborty; Christian G Cerda-Smith; Ryan N Bratton; Natalie E Maurer; Ethan M Senser; Michael Novak
Journal:  J Org Chem       Date:  2013-07-01       Impact factor: 4.354

4.  Pd(II)-catalyzed ortho arylation of 2-arylbenzothiazoles with aryl iodides via benzothiazole-directed C-H activation.

Authors:  Qiuping Ding; Huafang Ji; Dan Wang; Yuqing Lin; Weihua Yu; Yiyuan Peng
Journal:  J Organomet Chem       Date:  2012-07-15       Impact factor: 2.369

Review 5.  Choose and Use Your Chemical Probe Wisely to Explore Cancer Biology.

Authors:  Julian Blagg; Paul Workman
Journal:  Cancer Cell       Date:  2017-07-10       Impact factor: 31.743

6.  Catalyst- and Additive-Free Method for the Synthesis of 2-Substituted Benzothiazoles from Aromatic Amines, Aliphatic Amines, and Elemental Sulfur.

Authors:  Xiaoming Zhu; Fengru Zhou; Yuan Yang; Guobo Deng; Yun Liang
Journal:  ACS Omega       Date:  2020-05-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.